To determine whether METTL3 affects the growth of RB cells in vivo, we established a subcutaneous tumour model by injecting METTL3‐down‐regulated Y79 cells and control cells (shNC, shRNA1 and shRNA2) into nude mice. Here, METTL3 is linked to neoplasm.